Vendor review
Tianjin Ruiwang New Material Technology Co reviews
Tianjin Ruiwang New Material Technology Co reviews from 182 independent lab tests (Retatrutide, Tirzepatide and GHK-Cu): grade A, purity and fill accuracy. Is Tianjin Ruiwang New Material Technology Co legit? See what its vials showed.
Grade A182 independent lab tests0 peptides listedShips from China
Tianjin Ruiwang New Material Technology Co's website could not be reached at the last check. Links to the shop are disabled.
What the lab tests show
182 tests on record, newest first. Scores are purity divided by ten.
| Date | Product | Purity | Quantity | Identity | Certificate |
|---|---|---|---|---|---|
| Oct 8, 2026 | PT-141 | 99.9 % | 9.14 mg of 10 mg (-9 %) | Pass | View |
| Oct 6, 2026 | Retatrutide | 11.2 % | 30.5 mg of 30 mg (2 %) | Pass | View |
| Oct 1, 2026 | 5-Amino-1MQ | 99.9 % | 51.1 mg of 50 mg (2 %) | Pass | View |
| Sep 24, 2026 | Retatrutide | 99.9 % | 14.99 mg of 15 mg (0 %) | Pass | View |
| Sep 24, 2026 | GHK-Cu | 99.9 % | 99.99 mg of 100 mg (0 %) | Pass | View |
| Sep 24, 2026 | BPC-157 | 99.9 % | 8.79 mg of 10 mg (-12 %) | Pass | View |
| Sep 4, 2026 | NAD+ | 98.1 % | 365 mg of 500 mg (-27 %) | Pass | View |
| Aug 28, 2026 | Retatrutide | 99.7 % | 16.3 mg of 20 mg (-19 %) | Pass | View |
| Aug 25, 2026 | Retatrutide | 99.7 % | 9.3 mg of 10 mg (-7 %) | Pass | View |
| Aug 13, 2026 | TB-500 | 99.4 % | 4.62 mg of 5 mg (-8 %) | Pass | View |
| Aug 13, 2026 | Tesamorelin | 15 mg | Fail | View | |
| Aug 12, 2026 | Tesamorelin | 99.4 % | 5.35 mg of 5 mg (7 %) | Pass | View |
| Aug 12, 2026 | GHK-Cu | 99.9 % | 43.7 mg of 100 mg (-56 %) | Pass | View |
| Aug 12, 2026 | Retatrutide | 99.9 % | 24.3 mg of 30 mg (-19 %) | Pass | View |
| Aug 9, 2026 | Tirzepatide | 99.8 % | 20.5 mg of 20 mg (2 %) | Pass | View |
| Aug 5, 2026 | GHK-Cu | 99.9 % | 57.3 mg of 100 mg (-43 %) | Pass | View |
| Aug 5, 2026 | Retatrutide | 99.9 % | 8.05 mg of 10 mg (-20 %) | Pass | View |
| Aug 3, 2026 | 5-Amino-1MQ | 99 % | 5.46 mg of 10 mg (-45 %) | Pass | View |
| Aug 3, 2026 | NAD+ | 98.3 % | 333 mg of 500 mg (-33 %) | Pass | View |
| Jul 21, 2026 | Tesamorelin | 99.9 % | 9.62 mg of 10 mg (-4 %) | Pass | View |
| Jul 1, 2026 | BPC-157 | 99.9 % | 4.47 mg of 5 mg (-11 %) | Pass | View |
| Jun 17, 2026 | Retatrutide | 99.7 % | 26.6 mg of 30 mg (-11 %) | Pass | View |
| Jun 12, 2026 | Tesamorelin | 10 mg | Fail | View | |
| Jun 8, 2026 | GHK-Cu | 99.9 % | 88.7 mg of 100 mg (-11 %) | Pass | View |
| Jun 8, 2026 | 5-Amino-1MQ | 99.7 % | 43.8 mg of 50 mg (-12 %) | Pass | View |
| Jun 5, 2026 | Retatrutide | 99.9 % | 25 mg of 30 mg (-17 %) | Pass | View |
| May 8, 2026 | Cagrilintide | 99.9 % | 11.4 mg of 10 mg (14 %) | Pass | View |
| May 6, 2026 | TB-500 | 95.4 % | 4.02 mg of 5 mg (-20 %) | Pass | View |
| May 6, 2026 | Tesamorelin | 99.9 % | 14.2 mg of 15 mg (-5 %) | Pass | View |
| May 6, 2026 | GHK-Cu | 99.9 % | 48.7 mg of 50 mg (-3 %) | Pass | View |
| May 6, 2026 | BPC-157 | 99.9 % | 9.89 mg of 10 mg (-1 %) | Pass | View |
| Apr 28, 2026 | GHK-Cu | 99.9 % | 47.3 mg of 50 mg (-5 %) | Pass | View |
| Apr 28, 2026 | GHK-Cu | 99.9 % | 127.4 mg of 100 mg (27 %) | Pass | View |
| Apr 28, 2026 | Retatrutide | 99.9 % | 17.7 mg of 15 mg (18 %) | Pass | View |
| Apr 28, 2026 | TB-500 | 5 mg | Fail | View | |
| Apr 28, 2026 | Tesamorelin | 99.5 % | 13.3 mg of 15 mg (-11 %) | Pass | View |
| Apr 28, 2026 | Tesamorelin | 99.9 % | 12.8 mg of 15 mg (-15 %) | Pass | View |
| Apr 28, 2026 | Retatrutide | 99.9 % | 10.8 mg of 10 mg (8 %) | Pass | View |
| Apr 28, 2026 | Retatrutide | 99.9 % | 10.7 mg of 10 mg (7 %) | Pass | View |
| Apr 28, 2026 | GHK-Cu | 99.9 % | 35.6 mg of 50 mg (-29 %) | Pass | View |
| Apr 28, 2026 | BPC-157 | 99.9 % | 5.06 mg of 10 mg (-49 %) | Pass | View |
| Apr 28, 2026 | BPC-157 | 99.9 % | 4.63 mg of 10 mg (-54 %) | Pass | View |
| Apr 28, 2026 | Semaglutide | 99.9 % | 29.4 mg of 30 mg (-2 %) | Pass | View |
| Apr 28, 2026 | PT-141 | 10 mg | Fail | View | |
| Apr 28, 2026 | Ipamorelin | 98.4 % | 4.92 mg of 5 mg (-2 %) | Pass | View |
| Apr 28, 2026 | Tirzepatide | 99.9 % | 16 mg of 15 mg (7 %) | Pass | View |
| Apr 28, 2026 | Tirzepatide | 99.9 % | 62.9 mg of 60 mg (5 %) | Pass | View |
| Apr 26, 2026 | Ipamorelin | 98.8 % | 10.3 mg of 10 mg (3 %) | Pass | View |
| Apr 23, 2026 | Retatrutide | 98.3 % | 16.3 mg of 15 mg (9 %) | Pass | View |
| Apr 23, 2026 | Retatrutide | 98.3 % | 21.4 mg of 20 mg (7 %) | Pass | View |
| Apr 23, 2026 | Retatrutide | 99.9 % | 50.5 mg of 50 mg (1 %) | Pass | View |
| Apr 21, 2026 | Tesamorelin | 99.7 % | 25.3 mg of 20 mg (27 %) | Pass | View |
| Apr 21, 2026 | Tesamorelin | 99.5 % | 6.4 mg of 5 mg (28 %) | Pass | View |
| Apr 21, 2026 | TB-500 | 99.7 % | 10.6 mg of 10 mg (6 %) | Pass | View |
| Apr 13, 2026 | BPC-157 | 10 mg | View | ||
| Apr 13, 2026 | BPC-157 | 99.6 % | 11.4 mg of 10 mg (14 %) | Pass | View |
| Mar 13, 2026 | Retatrutide | 99.8 % | 16.6 mg of 15 mg (11 %) | Pass | View |
| Mar 10, 2026 | TB-500 | 5 mg | Fail | View | |
| Mar 10, 2026 | GHK-Cu | 99.9 % | 52.7 mg of 50 mg (5 %) | Pass | View |
| Mar 10, 2026 | BPC-157 | 10 mg | Fail | View |
What Tianjin Ruiwang New Material Technology Co sells
No current listings on record.
About Tianjin Ruiwang New Material Technology Co
Whatsapp: +8619033127116